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Multiparameter antibiotic resistance detection
based on hydrodynamic trapping of individual E.
coli†
Giampaolo Pitruzzello, *a Stephen Thorpe, b Steven Johnson, c
Adrian Evans,d Hermes Gadêlha e and Thomas F. Krauss a
There is an urgent need to develop novel methods for assessing the response of bacteria to antibiotics in a
timely manner. Antibiotics are traditionally assessed via their effect on bacteria in a culture medium, which
takes 24–48 h and exploits only a single parameter, i.e. growth. Here, we present a multiparameter ap-
proach at the single-cell level that takes approximately an hour from spiking the culture to correctly classify
susceptible and resistant strains. By hydrodynamically trapping hundreds of bacteria, we simultaneously
monitor the evolution of motility and morphology of individual bacteria upon drug administration. We show
how this combined detection method provides insights into the activity of antimicrobials at the onset of
their action which single parameter and traditional tests cannot offer. Our observations complement the
current growth-based methods and highlight the need for future antimicrobial susceptibility tests to take
multiple parameters into account.
Introduction
The excessive, inappropriate and often unnecessary use of
antibiotics has dramatically accelerated the development of
bacterial resistance.1,2 A key reason for this misuse, especially
for the overuse of broad-spectrum antibiotics, is the lack of
rapid and precise tests available to pinpoint specific antibi-
otics for a given infection. Most antimicrobial susceptibility
tests (ASTs) are currently based on defining susceptibility as
the inhibition of bacterial growth in the presence of antibi-
otics. The main limitation of these techniques is the need for
detecting division at the community level, given that a mini-
mum concentration of bacteria is needed to produce a detect-
able signal. For example, the traditional and still most com-
monly used clinical AST is based on the agar diffusion test or
the broth dilution technique, both of which take 24–48 h,
which is too slow for informing the correct choice of antibi-
otic in the early and often critical stages of an infection.3,4
Furthermore, culturing often favours certain bacteria over
others, so is biased.5 Genotyping can also lead to biases, as
the absence of specific resistance genes or mutations does
not guarantee susceptibility to a specific antibiotic.6
Since the majority of ASTs measures susceptibility of large
bacterial populations, they average over billions of organisms.
Thus, the response of individual bacteria is lost, which poten-
tially contains very relevant information. Collecting single-cell
statistically-rich data is crucial for unveiling underlying distri-
butions within a bacterial population; indeed, there is grow-
ing evidence for heterogeneity and differentiation into sub-
populations that can adopt specific strategies for developing
resistance, such as acting dormant or modifying their growth
rate.7 Hence, there is a need for new ways of defining and
characterising susceptibility that consider the heterogeneity
of bacterial populations and that offer rapid analysis.
Phenotyping susceptibility6,8 at the single-cell level is emerg-
ing as a possible candidate to meet these requirements.7,9,10
The interest towards single bacteria analysis has recently
gained significant attention, especially in the context of anti-
microbial resistance.7,8 An important requirement for single-
cell phenotyping is the availability of an immobilization tech-
nique that allows localising a significant number of single
bacteria at specific locations over time. One of the first plat-
forms proposed for single bacteria trapping and analysis is
the so-called mother machine.11 Here, a single bacterium
(the pole mother cell) is localised in a narrow dead-end
microfluidic channel which constricts growth along a single
direction in order to follow multiple generations. This config-
uration is advantageous for studying cell aging and prolifera-
tion over extended periods of time.12–14 However, the accu-
mulation of secreted products and the increased shear along
the channel might affect bacteria phenotype and division
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time.15 Notably, a slight variant of this platform has recently
been applied to the study of antimicrobial resistance by mea-
suring the differential growth rate of E. coli upon exposure to
antibiotics in multiple dead-end channels.16
Single bacteria localisation can also be achieved through a
variety of other techniques, such as optical17,18 or acoustic19
trapping, hydrogel or agarose immobilisation assays,4 droplet
microfluidics,20–22 dielectrophoresis23,24 or by antibodies
tethered on the sensor surface and binding to proteins on
the bacteria membrane.25,26
In order to achieve the immobilisation of hundreds of sin-
gle bacteria over time, here we employ hydrodynamic trap-
ping9,10 within micro wells because it is label-free, it can
readily be integrated into a microfluidic assay and it is highly
scalable, thereby enabling the creation of high-density trap
arrays. Compared to the previously mentioned trapping
methods, hydrodynamic trapping affords single cell mechani-
cal immobilisation over time at specific, regular and known
locations. On one hand, the trapping principle itself (i.e. me-
chanically impeding bacteria swimming), eliminates the need
for molecular recognition elements (i.e. antibodies which are
costly and may not be available for a particular strain), the
generation of droplets or external equipment such as a laser,
for either trapping or droplets readout, or acoustic trans-
ducers. On the other hand, arraying single cells at regular po-
sitions facilitates automation in the detection and data analy-
sis, which is not straightforward to control with antibodies
tethering or agarose immobilisation, for example.
Furthemore, this method offers the possibility of continuous
medium recirculation, which ensures that the trapped cells
are exposed to a constant environment over time, unlike the
mother-machine inspired devices. Finally, daughter cells fol-
lowing division are removed from the trapping areas, thus
ensuring truly single cell assay. However, hydrodynamic trap-
ping suffers from relatively poor trapping efficiency, as we
will detail later on. The method has been pioneered for and
widely applied to the study of eukaryotic cells, exploiting ei-
ther micro-wells structures acting as mechanical bar-
riers9,10,27 or the difference in hydraulic resistance between
different fluidic paths to drive cells towards small
openings.28–30 However, it has not been applied as extensively
to the study of single bacterial cells, with only a few examples
available in the relevant literature.31,32
For most of the aforementioned bacteria trapping plat-
forms, growth is employed as a signature of susceptibility to
antibiotics, either by direct imaging4,16 or by indirect mea-
surements such as fluorescence21,22 or Raman analysis.23 Re-
cent studies have instead focused on motility as the signature
of bacterial susceptibility.33–35 Motility is a fundamental prop-
erty of many types of bacteria which plays a crucial role in the
early stages of infection.36,37 In contrast to a growth-based as-
say, motility could represent a more rapid way of assessing
bacterial viability upon drug administration and to classify re-
sistant strains. Highly sensitive methods for detecting motility
have included the use of an AFM cantilever to record motility-
induced vibrations33,34,38 and fluctuations of the voltage drop
across a micro channel.35 However, these techniques usually
interrogate hundreds of bacteria in parallel, which makes
them unable to follow the critical dynamics response of indi-
vidual organisms. The effect of antibiotics on the motility at
the single-cell level, has so far only been studied using anti-
body tethering in conjunction with surface plasmon reso-
nance imaging (SPRi).26 All of these tests use motility as the
only signature to determine susceptibility, while the response
of bacteria to an antibiotic is a multiparameter problem. To
this purpose, we also exploit bacterial morphology as a second
indicator of response to antibiotics, which has already been
shown to be a suitable parameter to detect susceptibility.4,39
However, to the best of our knowledge, the combined analysis
has never been performed at the single-cell level before.
Our assay consists of arrays of cup-shaped structures act-
ing as mechanical barriers to trap live bacteria flowing in a
microfluidic channel. The trap dimensions are designed to
fit a single E. coli per trap in most cases, as illustrated in
Fig. 1. The hydrodynamic interaction between the bacteria
and such traps is shown to carry rich information about bac-
terial behaviour, including sensitivity to changes in cell phe-
notype in response to environmental challenges, including
Fig. 1 (a) Sketch of the hydrodynamic trap array. Traps (in green) are fabricated in SU8, an electron beam negative resist, on a glass slide, and are
sealed with a PDMS channel to allow injection of the bacterial solution. (b) Phase contrast image of a section of a microfluidic channel and trap
array, some of which are populated with bacteria. (c) Atomic force microscopy (AFM) image of a single trap on a microscope slide.
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antibiotic action. In particular, we have identified three sig-
natures of the bacterial response to such challenges: the frac-
tion of bacterial population entering the traps (hydrodynamic
trapping efficiency), the amplitude of the movement of each
bacterium within the trap, and the bacterial morphology
(length of the bacterium). We demonstrate that these signa-
tures, which are dependent on both motility and morphology,
can be used to successfully classify resistant and susceptible
strains of E. coli to different antibiotics in about an hour
from spiking the culture. The method also provides useful in-
sights into the antibiotic mode of actions and their effect of
bacterial viability over time, right at the onset of their action.
Our results are then correlated with a traditional micro-
dilution assay in order to directly link our phenotypic signa-
tures to a standard method of detecting susceptibility.
Results
A preliminary set of experiments is conducted as a control to
prove the ability of the assay to discern motility at the single
bacteria level. In particular, we have studied the behaviour of
two different strains of E. coli in different viability conditions.
We have used wild type E. coli MG1655 (colour-coded in
green) as a motile peritrichous strain, meaning that is has
multiple flagella (four on average) arranged randomly over
the cell. In addition, we ran trapping assays using a non-
motile E. coli strain, BW25113, which has a reduced expres-
sion of flagella genes and is thus unable to swim40 (colour-
coded in orange). BW25113 is then exposed to heat to kill the
cells and provide a control group.
Intensity traces and evaluation of bacterial motility
Videos of the trapping experiments are recorded and subse-
quently post processed by using a custom MATLAB script. In
particular, the average pixel intensity (or luminance) over
each trap area is traced over time (see movie S1† for an illus-
tration of the operation principle). Typical traces illustrating
the time variation are shown in Fig. 2(a) and (b). The pres-
ence of bacteria causes an abrupt change in the intensity
across the trap area, while motion results in increased fluctu-
ations due to oscillations of constricted bacteria. We quantify
this degree of motility by normalising the standard deviation
of the trapped bacterium to the background noise calculated
for the empty trap (bacterial motility = σtrapped/σempty). For ex-
ample, a motility of 10 means that the standard deviation
produced by the trapped bacterium is ten times greater than
the background noise. Fig. 2(a) shows a typical example of a
trapped motile E. coli MG1655, while 2(b) illustrates a typical
non-motile E. coli BW25113. The difference in the trace noise
is very apparent. Fig. 2(c) and (d) show micrographs of an
empty and filled trap respectively.
We measured bacterial motility for both strains in inde-
pendent trapping experiments. In particular, three different
experiments were conducted with the motile E. coli MG1655
strain and two with the non-motile BW25113, each consisting
of three 5-minute-long videos being recorded and analysed.
Fig. 2(e) shows the distributions of motility values for the dif-
ferent conditions, along with the measured values of trapping
efficiency ηh (see next paragraph). The distributions are fitted
to gaussian curves in order to retrieve an average motility
and the relative spread. Motile E. coli MG1655 (green data in
Fig. 2(e)) showed an average motility of (8.0 ± 0.4), while the
non-motile BW25113 (orange data in Fig. 2(e)) showed a mo-
tility of (1.7 ± 0.1). We then repeated the trapping experiment
with dead bacteria that had been exposed to a heat treatment
of 60 °C for 2 hours. The relative distribution is represented
by the black data in Fig. 2(e), which produced an average mo-
tility for dead bacteria of (1.4 ± 0.1). This shows that a
Fig. 2 Typical traces from motile (a) and non-motile (b) strains together with phase contrast micrographs of an empty (c) and a filled (d) trap. The
change in brightness (or luminance) is a signature of bacterial trapping, while variance is indicative of motion inside the trap. The light shaded areas
in (a) and (b) highlight the length of time that bacteria remain in the trap. The standard deviation σtrapped is calculated over this time frame, while
σempty is referred to the empty trap. The blue boxes in panels (c) and (d) represent the area over which the average pixel intensity is calculated.
Panel (e) shows the distributions of motility for motile (MG1655), non-motile (BW25113) and dead bacteria strains along with the measured trap-
ping efficiencies per trap.
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consistent measurement of motility can be obtained with our
trapping assay, which allows us to discriminate motile from
non-motile cells. Interestingly, we can also distinguish the
alive, non-motile BW25113 from the same strain after heat
treatment. The former shows a slightly higher and statisti-
cally relevant signal than the dead case, which is likely due to
motility mechanisms that do not require the active use of fla-
gella, such as gliding or twitching.41,42
Hydrodynamic trapping efficiency
The design principle of such hydrodynamic traps is optimised
to maximise the fluid flow through them.9,31,32 However, the
fluidic resistance is always much higher and the fluid velocity
much lower inside the traps compared to the surrounding re-
gions.31 The majority of fluidic streamlines thus diverts from
the interior regions of the trap because of the non-slip bound-
ary condition at each interface.43 This effect is qualitatively il-
lustrated in the insets of Fig. 3, which show the fluid velocity
with the associated streamlines obtained from a 2D FEM sim-
ulation in COMSOL Multiphysics. Thus, the trapping effi-
ciency of such assays is relatively low compared to
differential-pressure hydrodynamic trapping.
For these reasons the number of trapped bacteria is
strictly linked to bacterial motility. A passive object in the
flow is less likely to enter any of the traps as it will simply fol-
low the fluidic streamlines. The only chance for a non-motile
organism to get trapped is to happen to flow along one of the
few streamlines going through a trap. In contrast, a swim-
ming organism has an increased probability of getting
trapped because it can actively move across streamlines, due
to its rheotactic ability44 as well as because swimming natu-
rally increases the frequency of encountering a trap. This be-
haviour is qualitatively illustrated in Fig. 3 where bacteria are
tracked over time. For the non-motile strain BW25113 (panel
(a) and inset), bacterial trajectories follow the streamlines of
the underlying flow, thus tending to avoid the traps. In the
motile case of strain MG1655 (panel (b) and relative inset),
however, the trajectories are more segmented and bacteria
actively cross streamlines enabling them to enter the stag-
nant regions within the traps.
In order to quantify the efficiency of this process, we
consider the number of bacteria, N0, that swim through the
field of view in a given time period (typically 5 minutes, cor-
responding to the length of the recorded videos for each ex-
periment). Of these, Nh will enter a trap. The fraction of
bacteria can be used to define the hydrodynamic efficiency
ηh = Nh/N0. This quantity is then normalised to the number
of available traps in the field of view (typically ranging from
25 to 33). We have measured the efficiency from the same
set of experiments described in the previous paragraph and
have obtained values of (0.49 ± 0.02) %/trap for the motile
E. coli strain MG1655, (0.23 ± 0.01) %/trap for the non-
motile E. coli strain BW25113 and (0.21 ± 0.01) %/trap for
dead bacteria. Values are reported next to the corresponding
motility distributions in Fig. 2(e). These numbers corre-
spond respectively to about (16.2 ± 0.7) %, (7.6 ± 0.3) % and
(6.9 ± 0.3) % absolute trapping efficiencies for 33 traps over
5 minutes. The remaining probability of trapping for dead
organisms is expected because of the design of the traps
and because dead organisms still experience Brownian mo-
tion associated with any object suspended in a fluid. Nota-
bly, at the bacteria concentration we used (107 cfu ml−1),
nearly all the traps in the field of view were filled within the
5 minute long analysis. It is clear that motile bacteria are
approximately twice as likely to swim into a trap than non-
motile or dead ones. This result correlates well with the mo-
tility analysis, supporting the aforementioned connection be-
tween bacteria motility, ability to cross streamlines and,
consequently, trapping efficiency.
Fig. 3 Typical trajectories for a non-motile (a) and a motile strain (b) obtained by tracking E. coli BW25133 and MG1655, respectively. The trap lay-
out is superimposed and those traps that have been filled by one or more bacteria are shaded in red. Non-motile trajectories follow the stream-
lines of the fluid flow, which tend to avoid the stagnation regions, while trajectories of motile bacteria are more segmented, allowing more traps
to be filled. The insets show the fluid velocity field and associated streamlines obtained by a FEM simulation in COMSOL Multiphysics, illustrating
the streamlines diverting from the inner regions of the traps.
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Clearly, the absolute values of the trapping efficiency de-
pend on the fluid velocity relative to the bacteria swimming
speed. We can identify a lower and an upper bound for the
flow rate: a) if it is too small compared to the bacteria swim-
ming speed, bacteria are easily able to migrate across stream-
lines and enter a trap, but less likely to stay trapped for long
since they can swim against the (weak) flow; b) conversely, if
the fluid is too fast, the trapping efficiency drops because
cells are preferentially dragged along the channel. The opti-
mal flow rate balancing these two effects has been deter-
mined empirically to be between 10 and 15 nl min−1. There-
fore, a rate of 10 nl min−1 is employed in subsequent
experiments. Further details are provided in Fig. S1.†
Morphology selectivity
The physical geometry of the traps intrinsically selects bacte-
ria according to their size and shape. In order to illustrate
this point, we have studied the trapping process for bacteria
with different morphology by exploiting the natural size dis-
tribution within the same population of E. coli MG1655 and
for two different trap geometries. Fig. 4(a) and (b) show the
corresponding length and eccentricity distributions as deter-
mined from the residence time in the traps for the same type
of trap. Blue data represents bacteria that have escaped
within seconds of being trapped, while the red distributions
refer to those that were trapped for at least 3 minutes.
We note a clear difference in the trapping duration be-
tween different shapes of bacteria. Elongated bacteria,
characterised by a major axis a = (3.41 ± 0.51) μm and an ec-
centricity e of 0.97 ± 0.01, exhibit extended residence time
within the trap. Shorter bacteria ((2.14 ± 0.46) μm long and
with e = 0.91 ± 0.03) escape the traps immediately after hav-
ing entered. The reason for this marked difference is the fact
that the shorter and more rounded bacteria are able to rotate
more easily within the trap and thereby gain access to the
vertical gap between the vertical and horizontal trap walls.
Conversely, the motion of elongated bacteria is physically re-
stricted, so they remain trapped for longer. See movies S2
and S3† for an illustration of this mechanism.
This trapping effect is also explicitly demonstrated in
Fig. 4(c), where the distributions of width and length of
trapped bacteria only are shown for the two different geome-
tries sketched in the inset (geometry 1 and 2 colour-coded in
green and red respectively). The key differences between the
two are the width of the trap (1.83 μm and 1.66 μm for geom-
etry 1 and 2 respectively) and the vertical gap (455 nm and
315 nm, respectively). The larger these dimensions, the larger
the bacterium needs to be to remain trapped. In particular,
the size of the vertical gap controls the minimum width of
the bacteria to be trapped, while the width of the trap deter-
mines the minimum length of bacteria able to rotate within
the trapping area and thus escape.
Antimicrobial susceptibility assay
Having established that the hydrodynamic traps are sensitive
to both bacterial motility and shape, we now proceed to show
how these signatures can be used to provide a measure of
antibiotic susceptibility by classifying resistant and suscepti-
ble strains. The wild type motile E. coli MG1655 was used as
a susceptible strain. Resistant colonies were grown from the
same strain being modified by bacterial transformation with
specific plasmids encoding resistance to three different anti-
biotics, namely trimethoprim, ampicillin and kanamycin.
The susceptibility of the wild type and the minimum inhibi-
tory concentration (MIC) values were determined by a stan-
dard resazurin microdilution assay. We found MIC values of
1–2 μg ml−1 for trimethoprim, 4–8 μg ml−1 for ampicillin and
8–16 μg ml−1 for kanamycin. The same method was then
used to verify that the transformed strains were resistant to
>512 μg ml−1 of the three drugs (see the methods section
and Fig. S2 and S3† for more details). Furthermore, the via-
bility of the transformed colonies was proven by measuring
standard growth curves (see Fig. S4†).
We thus chose to expose the different strains in our trap-
ping experiments to a concentration of 10 μg ml−1 of each
drug, which corresponds to a few times the MIC for trimetho-
prim and ampicillin, and a near-MIC value for kanamycin.
The reason for selecting these three antibiotics lies in their
different modes of action, which allows us to demonstrate
the generality of our assay. Specifically, the bacteriostatic
antibiotic trimethoprim inhibits the synthesis of folic acid,45
while the bactericidal ampicillin and kanamycin inhibit the
synthesis of the cell wall46 and proteins,47 respectively.
Fig. 5 reports the results for the three different drugs ad-
ministered to both the susceptible and resistant strains.
Fig. 4 Length (a) and eccentricity (b) distributions of bacteria that
have entered a trap. The eccentricity is calculated by modelling the
rod-shaped E. coli as an ellipsoid. The blue curves represent bacteria
that have escaped within a few seconds, while the red curves refer to
bacteria that have been trapped for at least 3 minutes. The lengths are
fitted to Gaussian distributions, while the eccentricities with an asym-
metric beta distribution. (c) Shows the distribution of width and length
of trapped bacteria for the two different geometries sketched in the
inset.
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Rows report different antibiotics (ampicillin (AMP, panels (a–
c)), kanamycin (KAN, panels (d–f)) and trimethoprim (TRI,
panels (g–i)), respectively), while columns correspond to the
three quantities being evaluated as signatures (motility, trap-
ping efficiency and length, respectively). Red curves with cir-
cle markers refer to the susceptible wild type E. coli MG1655,
while blue curves with square markers are obtained for the
resistant strains. Each data point is calculated from data
extracted from a 5 minutes long video that is post-processed
to provide measures of total cell count, number of trapped
bacteria, intensity traces over the trap areas and cell mor-
phology. Values of motility and trapping efficiency are
normalised in each case in order to provide a homogeneous
measure between 0 and 1 and to facilitate comparison. Nega-
tive times serve as no-drug control measurements. The bacte-
rial samples were subsequently spiked with antibiotics at
time t = 0 and injected into the same chip (as indicated by
the vertical dashed lines). The only exception is represented
by the black dot-dash line in each graph, which is obtained
from a control experiment with the wild type E. coli MG1655
with no antibiotics being administered at any time point.
This control results serve to confirm that our phenotypical
signatures are not significantly affected by the microfluidic
environment. In fact, bacteria maintain constant motility and
show only a slight decrease in length over the entire duration
of the experiment, likely due to the pressure they experience
within the thin microfluidic channel. Therefore, any subse-
quent change in these signatures can be ascribed to the ac-
tion of the antibiotics.
The first column (panels (a), (d) and (g)) shows how the
bacterial motility varies over time following exposure of E.
coli to each of the three antibiotics. A clear and common de-
creasing trend is observed for the susceptible strain (red
curves with circle markers) for all three antibiotics, which
Fig. 5 Motility, trapping efficiency and length of susceptible (red curves with circle markers) and resistant (blue curves with square markers) E. coli
MG1655 exposed to ampicillin (AMP, panels (a–c)), kanamycin (KAN, panels (d–f)) and trimethoprim (TRI, panels (g–i)). A common decreasing
motility and trapping efficiency trend is observed for susceptible strains exposed to all three antibiotics (red curves in panels a, b, d, e, g and h).
Motility and trapping efficiency of resistant strains are not affected by KAN and TRI (blue curves in panels d, e, g and h), while a temporary loss is
measured during the first 1.5 hours of exposure to AMP (blue curves in panels a and b). The third column (panels c, f and i) illustrates a variety of
length responses to the antibiotics. Insets of these panels show single frames illustrating typical bacterial morphologies at different stages. Scale
bars correspond to 3 μm. The time at which the samples were spiked with antibiotics (t = 0) is indicated by the vertical black dashed lines in each
panel. The dot-dashed black curve in each graph refers to a no-drug control over the entire duration of the experiments, thus showing that bacte-
ria motility and morphology are not significantly affected by the microfluidic environment.
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directly corresponds to the similarly decreasing trapping effi-
ciency, as illustrated in the second column (red curves in
panels b, e and h). On the other hand, resistant strains (blue
curves with square markers) behave differently. Specifically,
ampicillin causes a rapid loss of motility also in the resistant
case. However, motility is almost totally recovered after 1.5 h
of continuous exposure to the drug (see panel (a)). The same
behaviour is reflected in the trapping efficiency (panel (b)).
Kanamycin and trimethoprim do not affect motility of resis-
tant strains, which remains constant upon exposure to the
drugs (blue curves in panels (d) and (g)) and, consequently,
trapping efficiency is not influenced either (blue curves in
panels (e) and (h)). These are already clear signatures that en-
able to detect resistance by differentiating the two strains.
Although the decreasing trends for the susceptible cases
are common to the three antibiotics, the dynamics and time
scales differ. These differences are confirmed by the morpho-
logical investigation over time reported in the third column
(panels (c), (f) and (i)). The combination of the motility and
the morphology information allows to probe the mechanisms
of antibiotic action, to explain the observed differences be-
tween the three drugs and to increase the confidence and de-
crease the time needed for the classification of resistance
and susceptibility.
In particular, ampicillin caused a significant decrease in
motility to the susceptible strain after about 1 hour from
spiking the culture (red curve in panel(a)). This reduction in
motility can be explained by two mechanisms. Firstly, ampi-
cillin is known to interfere with transcription of genes re-
quired for flagella synthesis and activation.48 Secondly, ampi-
cillin is a β-lactam antibiotic that binds to the penicillin
binding protein (PBP) and inhibits cross linking of the pepti-
doglycan layer in the cell wall, which is crucial for
maintaining cell morphology and balancing turgor pressure,
leading ultimately to cell lysis. Critically, the process of cell
lysis is preceded by an elongation phase and the formation
of a bulge structure,46 which make the swimming action less
efficient.49 This significant change in morphology can be
considered an early signature of susceptibility that occurs be-
fore cell lysis. It can be observed using our assay as a drop in
trapping efficiency and motility and confirmed by the length
analysis (see Fig. 5(c) and insets (i), illustrating the formation
of the bulge structure). Similarly, the resistant strain also ex-
periences a rapid loss of motility immediately after the expo-
sure to ampicillin (blue curve in Fig. 5(a)). This could pro-
duce ambiguity until the resistant strain recovers motility,
about 1.5 hours from the administration or until cell lysis is
observed in the susceptible case. Instead, the pronounced
filamentation process of the susceptible strain, allows to
clearly distinguish it from the resistant one, as the latter
shows a rapid decrease in length upon ampicillin exposure
(see panel (c) and relative inset (i)). This proves how the si-
multaneous assessment of multiple parameters could be ad-
vantageous in the classification process and provide a rich-
ness of information that would be otherwise lost in a single-
parameter assay.
The opposite situation is instead observed for kanamycin
(second row of Fig. 5). The morphological signature shows
rather similar behaviour for the susceptible and resistant col-
onies (Fig. 5(f)), as they both shrink upon the action of kana-
mycin, thus not providing notable insights. Conversely, a sig-
nificant loss of motility, and consequently of trapping
efficiency, is observed only 40 minutes after the administra-
tion of kanamycin to the susceptible strain (red curves in
Fig. 5(d) and (e)). Contrarily, motility and trapping efficiency
of resistant strains are almost not affected, remaining con-
stant over time (blue curves in Fig. 5(d) and (e)). This antibi-
otic is an aminoglycoside compound which binds to the 30S
ribosomal subunit causing misreading of the mRNA instruc-
tions and synthesis of non-functional and toxic peptides.47
This rapid loss of motility revealed here for susceptible bacte-
ria is likely due to lesser translation of motility genes.
Finally, trimethoprim, which indirectly affects DNA syn-
thesis by targeting the production of tetrahydrofolic acid
(THF),45 shows the least pronounced trend for the suscepti-
ble bacteria (Fig. 5(g) and (h)), likely because the lack of THF
does not have a strong and direct effect on flagella activation
and motion in general. The reason for the decreased motility
is instead a filamentary phenotypical change, which started
after around 1.5 hours of exposure to trimethoprim and
steadily increased over time (see Fig. 5(i) and the inset (iv)).
Filamentation is a defence mechanism adopted by the bacte-
ria which results in growth without division. The increased
length is also known to hamper the bacteria rotational diffu-
sion and swimming ability, so affecting both morphology
and motility.49 However, the motility signature can still be
considered the most valuable, as the length of the susceptible
and resistant strain are not clearly differentiated until about
2 hours of exposure to trimethoprim (Fig. 5(i)). Conversely,
the motility of resistant E. coli remains approximately con-
stant upon the action of trimethoprim (Fig. 5(g)). Experi-
ments with trimethoprim have been conducted in Mueller-
Hinton (MH) broth because the Luria-Bertani (LB) used else-
where contains traces of folic acid which might be taken up
by bacteria, thus partly counteracting the action of the drug.
Comparison to growth-based assays
In order to validate our results, two different controls have
been conducted to correlate our phenotypical signatures with
the standard definition of susceptibility based on growth and
bacterial division. The first evidence is represented by a bac-
terial count being performed on the same experiments de-
scribed above. The total number of bacteria swimming
through the channel is monitored over time. The results are
reported in Fig. S5.† The resistant strains continued to divide
even in the presence of the antibiotics following an expected
logistic model of growth. On the other hand, the number of
susceptible bacteria decreases in the presence of ampicillin,
given its bactericidal nature causing cell lysis, while trimetho-
prim and kanamycin prevent division, thus maintaining the
number of bacteria approximately constant over time.
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The second validation is a standard resazurin-based
microdilution assay. Wild type and transformed E. coli
MG1655 are grown in a standard 96-well plate in a serial dilu-
tion of antibiotics in order to verify their viability after an
overnight incubation. The conclusion from this experiment is
twofold: on one hand, we can confirm that we are indeed op-
erating in the susceptibility range of E. coli MG1655, while on
the other hand, it is clear that the transformation of the bac-
teria has been successful since the strains have acquired re-
sistance to >512 μg ml−1 of the respective antibiotics (see re-
sults in Fig. S2 and S3† for further details).
In conclusion, these final experiments enabled us to con-
firm the classification provided by our microfluidic platform
by linking our motility-morphology phenotypical signatures
to growth-based techniques, which represent the gold stan-
dard in the definition of susceptibility and resistance.
Discussion
The platform presented here enables multi-parameter suscep-
tibility analysis by linking motility and morphology in re-
sponse to drug exposure at the single-cell level. Our study
provides three major insights.
Firstly, we demonstrate that the combined assessment of
motility and morphology at the single-cell level could guide
the design of novel susceptibility tests and, more generally,
to study bacterial behaviour upon antibiotics administration.
While the two parameters have been used separately as indi-
cators of susceptibility,4,26,34,35,39 their combination at the
single cell level is presented here for the first time. In particu-
lar, we have shown the possibility to correctly classify suscep-
tible and resistant strains in less than two hours (from spik-
ing the culture) for three drugs of a very different nature, i.e.
drugs that are either bacteriostatic (trimethoprim) or use dif-
ferent modes of bactericidal action (ampicillin and kanamy-
cin). This combination of information from the two domains
enabled us to confirm the different modes of action of the
antibiotics and to increase the confidence in the classifica-
tion by selecting the best indicator for each drug. Our pheno-
typical signatures are correlated to the standard growth-
based definition of susceptibility by quantifying bacterial pro-
liferation within the microchannel and by a standard micro-
dilution assay.
Secondly, the trapping assay, by operating at the level of
individual cells, is able to respond on short timescales. In
contrast, traditional bulk tests based on detecting bacterial
growth cannot achieve such a short time resolution, because
of their intrinsic averaging procedure, which occurs over bil-
lions of cells.9,16 Our approach directly analyses a significant
number of individual cells in parallel and averages only after
the actual readout. This feature has also been exploited in
other single bacteria works, even if a truly single cell level is
either not achieved34,35,38 or the throughput capability is
lower.17,18,26 Here, changes in motility and morphology are
recorded on the timescale of the antibiotic action, thereby
not only providing a rapid assessment of susceptibility but
also information regarding the kinetics and time evolution of
antibiotic action.
Finally, the assay can be tuned to be selective. Even
though we do not use molecular recognition methods such
as antibodies, we can separate bacteria according to size,
shape and motility, as shown in Fig. 2 and 4(a) and (b). Our
method also allows to choose the size of the bacteria to be
trapped by modifying the trap geometry (Fig. 4(c)). This fea-
ture can be advantageous for tuning the assay to be selective
to certain bacteria, potentially extending its employability to
cocci organisms and to polymicrobial cases. We also note
that the size-selectivity could be used to filter bacteria in
terms of size or shape in a microfluidic circuit. The geometry
of the traps could be adjusted along the same microfluidic
channel in order to trap progressively longer/larger bacteria
and to study them at different stages of their life cycle or in
different conditions.
The main limitation of our approach is that it works for
motile strains. Even though non-motile bacteria can be
trapped, their trapping efficiency is rather low, which limits
the multi-parametric capability of the assay. Nevertheless,
motile strains are responsible for a large variety of infections
and motility plays a fundamental role in early-colonisation,
chemotaxis and in the growth and proliferation of
biofilms.36,37
In the context of antimicrobial resistance (AMR), one
could envisage a stand-alone chip with several channels in or-
der to test multiple antibiotics in parallel, potentially at dif-
ferent concentrations, and provide insights into the antibiotic
activity at the onset of its action. We have already observed
significant changes on a timescale of a few hours from spik-
ing the culture. More generally, the assay offers a unique
platform that is able to localize and confine hundreds of in-
dividual bacteria enabling them to be studied in parallel as
well as allowing for high-throughput time-dependent analy-
sis. Furthermore, localisation via hydrodynamic trapping
does not require expensive consumables or complex instru-
mentation, such as those required by antibody-based capture
or optical traps. This simplicity is a great advantage for moni-
toring cell behaviour over time, while probing the heteroge-
neity that is typical of bacterial populations.
Methods
Traps and microfluidic fabrication
Traps are fabricated in the negative electron beam resist SU8
on standard microscope slides. The access gap is typically 1.7
μm wide, the vertical bars are 4 μm long, the horizontal gap
is typically 300 nm wide and all the blocks are 2.1 μm tall.
The microfluidic channel is 1.5 μm deep, 170 μm wide and
several mm long. It is made out of PDMS by mixing the sili-
con elastomer and the curing agent (DowCorning) in a 7 : 1
ratio. The mixture is poured onto the SU8 mould on a silicon
substrate featuring 8 parallel channels, cured for at least 12 h
at 60 °C and peeled off. The PDMS stamp is permanently
bonded to the microscope slide with the traps by oxygen
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plasma treatment (22sccm of oxygen for 25 seconds at a DC
voltage of about 180 V).
Bacteria culturing, transformation and experiments
E. coli MG1655 and BW25113 were grown overnight at 37 °C
to saturation phase in Luria-Bertani (LB) or Muller-Hinton
(MH) broth, before being diluted in LB or MH to a concentra-
tion of 107 cfu ml−1. Bacterial transformation was achieved
through electroporation in order to facilitate plasmid uptake.
Details about the plasmid selection and the transformation
process can be found in the ESI.† Before starting every experi-
ment, the microfluidic chips were flushed with a 1% solution
of bovine serum albumin (BSA) in phosphate buffer saline
(PBS) solution for 30 minutes by using a syringe pump at 1 μl
min−1 to prevent attachment of bacteria to surfaces. The bac-
terial sample is then injected at a flow rate of 10 nl min−1.
HD videos were recorded with a DSLR camera (Nikon D3300)
at 50 fps connected to an inverted phase contrast microscope
(Leica DM IRB) equipped with a 60× magnification objective.
Microdilution resazurin assay
The microdilution assay has been performed on standard 96-
well plates by exposing wild type and transformed E. coli
MG1655 to a serial dilution of ampicillin, kanamycin and tri-
methoprim in order to determine their MIC and to verify that
the transformed strains have acquired resistance to the anti-
biotics. Resazurin is employed as a reporter dye to indicate
the viability status of the cells. Detailed procedures are
reported in the ESI† and results in Fig. S2 and S3.†
Growth curve assay
The growth curve assay has been carried out by measuring
the optical density (OD) of the growing colonies with a time
resolution of 20 minutes. Growth curves are obtained for the
wild type E. coli MG1655 and for the three transformed
strains. Detailed procedures and resulting curves are in-
cluded in the supplementary information (Fig. S4†).
Data analysis
Videos were post-processed with a custom-written MATLAB
script which converts them into grayscale and subtracts the
median frame calculated over the entire duration of the
videos. A region of interest (ROI) was centred on each trap to
define the area over which the average pixel intensity is calcu-
lated. Typically, 33 traps are present in each field of view and
videos are 5 minutes long. Intensity traces were obtained for
each trap over time and were used to calculate the standard
deviation corresponding to the trapping events and for
counting the bacteria. The total number of cells swimming
through the field of view in each video is of the order of sev-
eral hundreds (up to 2000 in some cases). The number of
trapped bacteria is of the order of several tens of individuals,
up to 150 in some cases. Tracking was performed on one-
minute long videos with the TrackMate extension of
ImageJ.50 Cell detection and length measurements were
achieved with the MATLAB regionprop function after being
manually calibrated for around 200 cells. This calibration
procedure is required because of the typical halos present in
phase contrast micrographs which cause misjudgement of
the cell boundaries. We explicitly verified that the correction
factor was constant within a ∼5% error across four indepen-
dent experiments, so that it was not necessary to repeat the
calibration for each experiment.
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